Rocket (Eruca vesicaria)

Rocket (Eruca vesicaria), commonly called arugula, contains glucosinolates—particularly glucoerucin—which are hydrolyzed by myrosinase into bioactive isothiocyanates such as erucin. These isothiocyanates modulate detoxification enzymes and exert antigenotoxic and anti-inflammatory effects at the cellular level.

Origin & History

Rocket (Eruca vesicaria) is a leafy cruciferous vegetable native to the Mediterranean region, traditionally used in North African and Middle Eastern cuisines and folk medicine. The plant belongs to the Brassicaceae family and is processed into extracts through sequential solvent extraction methods (chloroform, ethyl acetate, butanol, and aqueous fractions) for research applications.

Historical & Cultural Context

Rocket is a traditionally used medicinal plant from Algeria, supporting its historical role in North African traditional medicine systems. While specific historical applications are not detailed in available sources, traditional use includes applications for male reproductive health.

Health Benefits

• Antigenotoxic protection: Demonstrated protective effects against genetic damage with inhibition rates of 0.2-0.6 at intermediate concentrations (Evidence: In vivo animal studies)
• Anti-inflammatory activity: Molecular docking studies indicate strong interactions with inflammation-related targets (Evidence: Preliminary mechanistic studies)
• Antimicrobial properties: Leaf extracts showed 44-87% growth reduction against oomycete pathogens at 30mg applications (Evidence: In vitro studies)
• Stress response enhancement: Upregulates 51 genes involved in stress response pathways including transcription factors (Evidence: Gene expression analysis)
• Traditional reproductive health support: Historically used for male reproductive health applications (Evidence: Traditional use only)

How It Works

Glucoerucin, the primary glucosinolate in Eruca vesicaria, is enzymatically converted by myrosinase to erucin, an isothiocyanate that induces Phase II detoxification enzymes—including glutathione S-transferase and quinone reductase—via the Nrf2/ARE pathway, enhancing cellular antioxidant defenses. Erucin also suppresses NF-κB signaling, reducing downstream expression of pro-inflammatory cytokines such as TNF-α and IL-6. Molecular docking data suggest that phytochemicals in rocket form strong binding interactions with COX-2 and other inflammation-related protein targets, contributing to its observed anti-inflammatory activity.

Scientific Research

The available research consists primarily of in vitro, animal, and mechanistic studies rather than human clinical trials. Key findings include demonstrated antigenotoxic activity in vivo at 1.25-2.5 mg/ml concentrations and confirmed safety at doses up to 5000 mg/kg in acute toxicity testing. No human RCTs or meta-analyses with PMIDs were identified in the provided research.

Clinical Summary

Antigenotoxic effects have been demonstrated primarily in in vivo animal studies, where rocket extracts showed inhibition rates of 0.2–0.6 against mutagen-induced DNA damage at intermediate concentrations, indicating a dose-dependent protective response. Anti-inflammatory activity has been supported by molecular docking studies rather than large-scale human randomized controlled trials, which limits the directness of translation to clinical practice. No large human RCTs have yet quantified optimal therapeutic dosing for rocket-derived compounds. The current evidence base is preliminary but mechanistically plausible, warranting future Phase I/II human trials.

Nutritional Profile

Rocket (Eruca vesicaria) is a low-calorie leafy green (~25 kcal/100g fresh weight) with the following key nutritional components: Macronutrients: protein ~2.6g/100g, carbohydrates ~3.7g/100g, dietary fiber ~1.6g/100g, fat ~0.7g/100g. Micronutrients: Vitamin K ~109mcg/100g (91% DV, high bioavailability as phylloquinone), Vitamin C ~15mg/100g, Vitamin A ~119mcg RAE/100g (primarily as beta-carotene ~1424mcg), folate ~97mcg/100g, calcium ~160mg/100g (bioavailability moderate at ~17% due to moderate oxalate content), potassium ~369mg/100g, magnesium ~47mg/100g, iron ~1.46mg/100g (non-heme, enhanced by co-consumed Vitamin C). Bioactive compounds: glucosinolates ~95-180mg/100g fresh weight, predominantly glucoerucin (~60% of total glucosinolate fraction) and glucoraphanin, which hydrolyze via myrosinase to erucin and sulforaphane respectively upon tissue disruption — these isothiocyanates are primary drivers of antigenotoxic and antimicrobial activity; flavonoids including quercetin-3-glucoside, isorhamnetin, and kaempferol glycosides at combined ~30-50mg/100g; chlorophyll a and b at ~120-200mg/100g; carotenoids including lutein and zeaxanthin at ~3.5mg/100g combined (bioavailability enhanced by dietary fat co-consumption). Erucic acid is present in seeds but negligible in leaves. Oxalate content is relatively low (~70mg/100g) compared to spinach, making mineral bioavailability moderately favorable. Glucosinolate bioavailability is highest in raw consumption; cooking degrades myrosinase activity, reducing isothiocyanate yield by up to 50-70% unless gut microbiota partially compensate.

Preparation & Dosage

Extract concentrations studied: 0.625-5 mg/ml in in vitro/in vivo models, with 1.25-2.5 mg/ml showing optimal antigenotoxic effects. Acute toxicity studies confirmed safety up to 5000 mg/kg in animal models. Human therapeutic dosages have not been established through clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Broccoli sprouts, Sulforaphane, Quercetin, Curcumin, N-Acetylcysteine

Safety & Interactions

Rocket is generally regarded as safe when consumed as a food, but high-dose concentrated extracts may cause gastrointestinal discomfort, including bloating or nausea, particularly in individuals sensitive to cruciferous vegetables. Because glucosinolate metabolites can mildly inhibit thyroid peroxidase activity, individuals with hypothyroidism or those taking thyroid medications such as levothyroxine should exercise caution with large supplemental doses. Rocket contains moderate levels of vitamin K, which may interfere with anticoagulant therapy—particularly warfarin—by reducing its efficacy; patients on blood thinners should maintain consistent intake. Safety data in pregnancy and lactation are insufficient to recommend supplemental doses beyond normal dietary consumption.